Kwality Pharmaceuticals Profit & Loss Annual

BSE: 539997 | NSE: - | ISIN: INE552U01010 | Sector: Biotechnology & Drugs

869.90 +7.20 (0.83%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	307.17	251.03	456.19	262.01
Total Revenue	307.17	251.03	456.19	262.01
Costof Revenue Total	153.18	110.07	200.60	165.59
Gross Profit	153.99	140.96	255.58	96.42
Selling/ General/ Admin Expenses Total	32.56	29.96	20.15	15.90
Depreciation/ Amortization	19.56	14.96	10.69	6.49
Unusual Expense( Income)	7.10	16.53	-	-
Other Operating Expenses Total	55.11	50.86	63.77	51.67
Total Operating Expense	267.52	222.38	295.21	239.66
Operating Income	39.66	28.65	160.97	22.36
Interest Inc( Exp) Net- Non- Op Total	-103.87	-60.20	-29.17	-26.72
Other Net	1.83	2.89	3.51	1.59
Net Income Before Taxes	31.10	25.57	161.57	21.27
Provisionfor Income Taxes	7.48	6.29	41.63	6.38
Net Income After Taxes	23.62	19.28	119.94	14.89
Minority Interest	0.18	0.09	0.05	0.26
Net Income Before Extra Items	23.80	19.37	119.99	15.15
Net Income	23.80	19.37	119.99	15.15
Income Availableto Com Excl Extra Ord	23.80	19.37	119.99	15.15
Income Availableto Com Incl Extra Ord	23.80	19.37	119.99	15.15
Diluted Net Income	23.80	19.37	119.99	15.15
Diluted Weighted Average Shares	1.05	1.04	1.04	1.04
Diluted EPS Excluding Extra Ord Items	22.76	18.67	115.64	14.60
Diluted Normalized EPS	27.92	30.64	115.64	14.60
Gain( Loss)on Saleof Assets	-	0.54	-	-
Total Adjustmentsto Net Income	-	0.00	0.00	-